
|Articles|April 24, 2017
Novotech Signs MOU with South Korean Medical Center
Novotech announced that it has signed a Memorandum of Understanding (MOU) with South Korean medical institution, The Asan Medical Center.
Advertisement
Novotech announced that it has signed a Memorandum of Understanding (MOU) with South Korean medical institution, The Asan Medical Center (AMC). Under the agreement, the AMC will provide clinical trial advice while Novatech will assist in promoting the clinical research capabilities of the AMC internationally.
Read the full release
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
2
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
3
Accelerate Clinical Trials with AI-Enhanced Financial Management
4
SCOPE Summit 2026: Reducing Patient Burden Is the Foundation of Wearable Success in Oncology
5




